Thermo Fisher Scientific Inc (NYSE:TMO) over-valued by 10%
| Website | https://www.thermofisher.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $177,168,482,000 |
| Beta | 0.98491 |
| Average Volume | $1,282,727 |
| Last Dividend | 0.79% |
| Price on Jul 31, 2020 | $435.06 |
| Autochartist™ Valuation | $390.89 |
| Conclusion |
10% over-valued |
| Download Report |
